Abstract
Background: Frailty is a clinical condition characterised by loss of physiologic reserve and increased susceptibility to stressors. The prevalence of frailty is increased in cirrhotic patients. Molecular frailty biomarkers may reflect the dysregulation of physiological systems leading to this reduced physiological reserve, but as yet such complementary biomarkers have not been identified.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
